C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2001
11/27/2001	US6322770 Indazole vitronectin receptor antagonist pharmaceuticals
11/27/2001	CA2199941C Synthetic antibiotics
11/27/2001	CA2137009C Technetium-99m labeled peptides for imaging
11/27/2001	CA2050644C Process for the purification of insulins by chromatography
11/27/2001	CA2021912C Erythropoietin (epo) peptides and antibodies directed against these
11/26/2001	CA2346163A1 Complex for transferring an anionic substance of interest into a cell
11/22/2001	WO2001088178A2 Peptide substrates for direct measuring of enzyme activities
11/22/2001	WO2001088160A2 Vectors for dna delivery
11/22/2001	WO2001087928A1 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
11/22/2001	WO2001087323A2 Method for treating cartilage disorders
11/22/2001	WO2001041534A3 Pseudomycin phosphate prodrugs
11/22/2001	WO2001031036A3 Modified viral surface proteins which bind to cells of tumor vasculature
11/22/2001	WO2001030371A3 Novel chimeric analgesic peptides
11/22/2001	DE10023665A1 New human virus-inhibiting peptide, useful e.g. for treating viral or other infections or cancer, comprises fragment of alpha1-antitrypsin
11/22/2001	CA2408885A1 Vectors for dna delivery
11/21/2001	EP1156334A2 Method for screening a substance having promoting activity on hair growth
11/21/2001	EP1156329A2 Molecular modification assays
11/21/2001	EP1155037A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists therof, and their therapeutic uses
11/21/2001	EP1155034A1 Formation and anion-exchange of crystalline echinocandin ammonium salts
11/21/2001	EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
11/21/2001	EP0842191B1 Cyclosporin derivatives with anti-hiv activity
11/21/2001	EP0742902B1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
11/21/2001	EP0711305B1 Protegrins
11/21/2001	EP0536186B1 Bone and cartilage inductive proteins
11/21/2001	CN1323313A Process for the preparation of resin-bound cyclic peptides
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1075064C New benzoxazinedione derivatives, and producing process thereof and use
11/20/2001	US6319897 Peptides which inhibit complement activation
11/20/2001	US6319693 Cloning of chicken anemia virus DNA
11/20/2001	US6319690 Preparation and use of gene banks of human antibodies (“human-antibody libraries”)
11/20/2001	US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections
11/20/2001	US6319498 Amyloidogenic protein, or fragment thereof, modified with cis-decalin group, cholanoyl structure, cholyl group, diethylenetriaminepentaacetyl group, menthoxyacetyl group, fluorescein-containing group, or n-acetylneuraminyl group
11/20/2001	CA2224086C Conformationally-restricted combinatorial library composition and method
11/20/2001	CA2156390C Technetium-99m labeled peptides for diagnostic imaging
11/20/2001	CA2065022C Rubella peptides
11/20/2001	CA2008116C Glycine derivatives
11/15/2001	WO2001086296A2 Highly multiplexed reporter carrier systems
11/15/2001	WO2001086293A2 A method for designing and screening random libraries of compounds
11/15/2001	WO2001085763A2 Chimeric peptide immunogens their preparation and use
11/15/2001	WO2001085196A2 Cxcr4 antagonist treatment of hematopoietic cells
11/15/2001	WO2001015737A3 Method for coupling molecules
11/15/2001	WO2000078344A8 Prion protein peptides and uses thereof
11/15/2001	WO2000064484A3 Conjugate having a cleavable linkage for use in a liposome
11/15/2001	CA2408652A1 A method for designing and screening random libraries of compounds
11/14/2001	EP1153926A2 3,5-Dioxa-12-aza wurtzitane compound as molecular recognition agent and process of preparing same
11/14/2001	EP1152769A1 Yeast cell wall peptides and antibodies thereto
11/14/2001	EP0894002A4 Novel peptides which inhibit complement activation
11/14/2001	EP0688360B1 Bone stimulating factor
11/14/2001	EP0652900B1 Thrombin inhibitors
11/14/2001	CN1322212A Neuropeptide Y agaonists
11/13/2001	US6316594 Antimicrobial peptide isolated from parasilurus asotus and its uses
11/13/2001	US6316418 Regulated apoptosis
11/13/2001	US6316413 Peptide agonists of bradykinin B2 receptor
11/13/2001	US6316411 Protection against ischemia and reperfusion injury
11/13/2001	US6316406 Polypeptides
11/13/2001	US6316405 Cyclosporin a conjugates and uses therefor
11/10/2001	CA2347151A1 Method for screening a substance having promoting activity on hair growth
11/08/2001	WO2001083693A2 Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses
11/08/2001	WO2001083554A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083547A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	WO2001041811A3 Carrier peptide and method for delivery of molecules into cells
11/08/2001	WO2001037780A8 Urotensin-ii analogs
11/08/2001	WO2001018035A3 Muc-1 derived peptides
11/08/2001	WO2001007468A3 Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
11/08/2001	WO2000061194A3 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
11/08/2001	WO2000046238A8 Volatilizable solid phase supports for compound synthesis
11/08/2001	WO2000033888A3 Prodrug compounds and process for preparation thereof
11/08/2001	WO2000001841A3 Hyaluronic acid mimics and methods related thereto
11/08/2001	CA2414296A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2414290A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2406746A1 Methods and compositions for impairing multiplication of hiv-1
11/07/2001	EP1152060A1 5T4 tumour-associated antigen for use in tumour immunotherapy
11/07/2001	EP1152012A1 Tuberculosis vaccine and peptides
11/07/2001	EP1151143A1 Selection of proteins using rna-protein fusions
11/07/2001	EP1151100A1 Tau-conotoxin peptides
11/07/2001	EP1151095A1 Polypeptide variants with raised heparin-binding capacity
11/07/2001	EP1150999A1 Cyclosporin derivatives and method for the production of said derivatives
11/07/2001	EP1150995A1 A synthetic peptide disturbing intracellular signaling
11/07/2001	EP1150942A1 Improved compounds for protein binding
11/07/2001	EP1150701A2 Homing pro-apoptotic conjugates and methods of using same
11/07/2001	EP1150700A1 Antiangiogenic drugs
11/07/2001	EP0815139B1 Thrombin inhibitors based on the amino acid sequence of hirudin
11/07/2001	CN1321168A Laundry detergent and/or fabric care compositions comprising modified antimicrobial protein
11/07/2001	CN1074458C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
11/07/2001	CN1074422C Method for preparing HCV epitope-contg. separated polypeptide
11/06/2001	US6313094 Composition for inhibiting human immunodeficiency virus replication
11/06/2001	CA2032559C Endothelin antagonistic cyclic pentapeptides
11/01/2001	WO2001081426A2 Rgd (arg-gly-asp) coupled to (neuro)peptides
11/01/2001	WO2001081421A2 Synthetic peptides that bind to the hepatitis b virus core and e antigens
11/01/2001	WO2001081376A2 Apo-ai/aii peptide derivatives
11/01/2001	WO2001081325A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001	WO2001012233A3 Sustained release formulation of a peptide
11/01/2001	WO2000047775A9 Selection of proteins using rna-protein fusions
11/01/2001	US20010036921 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/01/2001	US20010036629 Sequencing of surface immobilized polymers utilizing microfluorescence detection
11/01/2001	CA2407167A1 Thrombopoietin receptor modulating peptide

1 ... 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 ... 423